First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone

View/ Open
Author
Lorenzo, Aileen
Young, Jonathan
Mohan, Abhishek
Pinnaka, Subhash
Lapidus, Kyle A. B.
Published Version
https://doi.org/10.1155/2016/7257489Metadata
Show full item recordCitation
Roberto, Aaron J., Aileen Lorenzo, Kevin J. Li, Jonathan Young, Abhishek Mohan, Subhash Pinnaka, and Kyle A. B. Lapidus. 2016. “First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone.” Case Reports in Psychiatry 2016 (1): 7257489. doi:10.1155/2016/7257489. http://dx.doi.org/10.1155/2016/7257489.Abstract
Synthetic cannabinoids- (SCs-) induced psychosis is a growing public health concern. It leads to significant impairment, including emotional distress, difficulty communicating, and other debilitating symptoms. In this case report, we discuss a patient with no previous history of psychotic symptoms, presenting with first-episode psychosis in the context of progressive, acutely worsening, disorganized, psychotic thoughts and behaviors following prolonged use of SCs. We also discuss relevant literature on SCs-induced psychosis, highlighting its prevalence, presentation, diagnosis, and recommended management. It is important to diagnose and treat SCs-induced psychosis as early and efficiently as possible, in order to alleviate symptoms while limiting functional impairment and emotional distress to the patient.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939204/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:27822163
Collections
- HMS Scholarly Articles [17842]
Contact administrator regarding this item (to report mistakes or request changes)